Healthcare
Welcome to our group, one dedicated to the healthcare professionals around our world, the support... View more
Organizer:
- Organized by
-
-
US begins first clinical trials testing cannabis products as migraine treatment
-
US begins first clinical trials testing cannabis products as migraine treatment
Researchers in the US have begun the nation’s first double-blind, randomized, placebo-controlled study testing the efficacy of cannabis in treating the major symptoms of migraines.
Some 16 states and Washington DC have legalized marijuana use by adults over the age of 21, while 37 states have legalized medical marijuana. New Mexico and Virginia will follow suit, but their legislation won’t take effect until the summer.
Despite the recent about-face by many state legislatures on marijuana, research into the efficacy of cannabis products such as THC and CBD has yet to begin in earnest, especially when it comes to chronic pain conditions such as migraine.
However, researchers at the University of California San Diego (UCSD) recently began the first clinical trials to test whether cannabis products might be both a safe and effective treatment for acute migraines.
-
0 Replies
Sorry, there were no replies found.
Log in to reply.